LUMIGAN gtt opht 0.1 mg/ml 3 fl 3 ml

7680559180052 CH-55918 S01EE03 11.09.0.
LUMIGAN gtt opht 0.1 mg/ml 3 fl 3 ml
LUMIGAN gtt opht 0.1 mg/ml 3 fl 3 ml
LUMIGAN gtt opht 0.1 mg/ml 3 fl 3 ml
1 / 3
google

Details

Product number
5591802
CPT
-
Packaging group
3 x 3
Unit
ml
Composition
bimatoprostum 0.1 mg, benzalkonii chloridum 200 µg, dinatrii phosphas heptahydricus corresp. phosphas 0.95 mg, acidum citricum monohydricum, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua purificata, ad solutionem pro 1 ml.

Articles (1)

Lumigan, 0.1 mg/ml, Augentropfen
Augentropfen
3 x 3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/06/2023
Patient information leaflet
Français
26/06/2023
Patient information leaflet
Italien
26/06/2023
Professional SmPC
Allemand
26/06/2023
Professional SmPC
Français
26/06/2023
Professional SmPC
Italien
26/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.1 MG Substance Wirkstoff (Principe actif)
(N/A)
200.0 UG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
0.95 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 61.20
Specialties list
Yes
Generic
No
SL addition date: 01/11/2010

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
55918
Drug name
Lumigan, Augentropfen
Galenic form
AUL
ATC Code
S01EE03
Authorization status
Z
Dispensation category
B
First authorization
31/05/2002
Authorization expiration date
31/12/9999
IT number
11.09.0.
Domain
Human medicine
Field of application
Glaukom

Packaging details

Description (FR)
LUMIGAN gtt opht 0.1 mg/ml 3 fl 3 ml
Description (DE)
LUMIGAN Gtt Opht 0.1 mg/ml 3 Fl 3 ml
Market launch
09/02/2010
Narcotic (BTM)
No

Other packaging sizes

LUMIGAN gtt opht 0.1 mg/ml fl 3 ml
1 x 3 ML
View